HOME >> BIOLOGY >> NEWS
On the loose: Urban coyotes thrive in North American cities

difficult to catch. They quickly learn how to avoid traps. But Gehrt and his colleagues distributed their traps widely throughout the greater Chicago area and successfully caught several animals. They put radio-tagged collars on the captured coyotes and then let them go.

The original estimates of the greater Chicago coyote population were woefully low. The researchers had expected to find a few small coyote packs here and there throughout the city, with total population numbers in the range of several dozen. But the animals were everywhere.

"We couldn't find an area in Chicago where there weren't coyotes," Gehrt said. "They've learned to exploit all parts of their landscape."

Since the beginning of the study, the researchers have caught and tagged more than 200 coyotes. They estimate that there may be somewhere between several hundred and a couple thousand coyotes living in Chicago .

Some of the animals live in city parks, while others live among apartment and commercial buildings and in industrial parks.

The funding agency, Cook County Animal Control and Conservation Medicine Coalition, renews the study every year because the researchers keep finding results that surprise them. This spring, Gehrt will publish the first round of papers from the last six years' worth of research.

The major findings include:

  • Coyotes help control Canada geese populations. It appears that coyotes are helping to curb the booming Canada goose population in urban areas by eating the eggs from the birds' nests.
  • Researchers found that, in Chicago , the annual population growth of Canada geese was reduced to an average of 1 to 2 percent per year, down from the 10 to 20 percent growth rates of a few years ago. Also, while coyotes can clean out several goose nests in one night, they don't actually eat all of the eggs. Rather, they usually carry the eggs away from the nest and bury them, saving the eggs until late
    '"/>


Contact: Stan Gehrt
Gehrt.1@osu.edu
614-292-1930
Ohio State University
3-Jan-2006


Page: 1 2 3

Related biology news :

1. Urban sediments after Hurricanes Katrina, Rita contained high levels of contaminants
2. Urbanization favors sedentary males
3. Urban Wildlife Management book something to crow about
4. Stress and the city: Urban birds keep cool
5. Urban ecology study witnessing the birth of a designer ecosystem
6. Why are coyotes getting more aggressive?
7. Tick-related disease thrives on cholesterol, study suggests
8. Gene thought to assist chemo may help cancer thrive
9. Species thrive when sexual dimorphism broadens their niches
10. Studies show that rockfish thrive with offshore platforms as their home base
11. ORNL-led study shows forests thrive with increased CO2 levels

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: the loose Urban coyotes thrive North American cities

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: